Women's Health Strategic Roundup: Earlier Intervention | Sep 08 – Oct 13, 2026
Women’s health market trends signal a competitive shift toward earlier…
Samsung Bioepis and Teva Expand SB41 and SB44 Biosimilar Partnership | Lucid Diligence Brief
This Lucid Diligence Brief explores Samsung Bioepis’ expansion of its…
Neuroscience Strategic Roundup: From Efficacy to Differentiation | Aug 25–Sept 29, 2026
Current neuroscience trends point to a broader competitive shift, as treatment…
Endocrinology Strategic Roundup: Beyond Glycemic Control | Aug 25 – Sept 28, 2026
Endocrinology Current Trends: For pharma teams, the competitive question is…
Basecamp Research $140M Series C: The Translation Test | Lucid Diligence Brief
This Lucid Diligence Brief examines Basecamp Research’s $140M Series C and…
Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Neuroscience Strategic Roundup | July 21–August 25, 2026
Neuroscience Strategic Roundup exploring Key Strategic Developments and…
Endocrinology Strategic Roundup | July 21–August 24, 2026
Endocrinology Strategic Roundup exploring Key Strategic Developments and…
Public Health Strategic Roundup | July 16–August 20, 2026
Public Health Strategic Roundup: Key Developments, Trends and Strategic…
Insulinova Partners with Ospedale San Raffaele | Lucid Diligence Brief
Avaí Bio and Insulinova Test Encapsulated Beta Cells With San Raffaele as…
Oncology Strategic Roundup | July 02 – Aug 07, 2026
Oncology Strategic Roundup exploring Developments and Competitive Shifts…
Genprex Roche Diagnostics TROP2 Collaboration | Lucid Diligence Brief
Genprex and Roche Diagnostics begin TROP2 assay validation to support…